Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TYRA
Stock Latest News
The Fly
Tyra Biosciences management to meet with Oppenheimer
5d ago
TYRA
Premium
The Fly
Tyra Biosciences initiated with a Strong Buy at Raymond James
6d ago
TYRA
Premium
Ratings
Tyra Bioscience’s Promising Developments in NMIBC and Achondroplasia Drive Buy Rating
18d ago
TYRA
Premium
Company Announcements
Tyra Bioscience Begins Phase 2 Study for Achondroplasia
18d ago
8K
TYRA
Premium
The Fly
Tyra Biosciences says first child dosed in BEACH301 trial
19d ago
TYRA
Premium
Ratings
Tyra Bioscience: Strategic Advancements and Financial Stability Justify Buy Rating
24d ago
TYRA
Premium
Ratings
Tyra Bioscience: Promising Clinical Trials and Financial Stability Justify Buy Rating
25d ago
TYRA
Premium
Company Announcements
Tyra Biosciences Advances Clinical Programs with Strong Financial Backing
25d ago
TYRA
Premium
The Fly
Tyra Biosciences reports Q2 EPS (47c), consensus (51c)
25d ago
TYRA
Premium
The Fly
Tyra Biosciences announces presentation on TYRA-300 preclinical results at ENDO
2M ago
TYRA
Premium
Ratings
Promising Outlook for Tyra Bioscience: Buy Rating Driven by TYRA-300’s Potential in NMIBC Treatment
2M ago
TYRA
Premium
Company Announcements
Tyra Bioscience Launches Phase 2 Study for TYRA-300
2M ago
8K
TYRA
Premium
The Fly
Tyra Biosciences says first patient dosed in Phase 2 study of TYRA-300
2M ago
TYRA
Premium
The Fly
Tyra Biosciences up 3% as RA Capital increases stake to 22.4%
3M ago
TYRA
Premium
Company Announcements
Tyra Bioscience Holds 2025 Annual Stockholders Meeting
3M ago
8K
TYRA
Premium
The Fly
Tyra Biosciences management to meet with Oppenheimer
3M ago
TYRA
Premium
The Fly
Tyra Biosciences assumed with an Overweight at Piper Sandler
4M ago
TYRA
Premium
Company Announcements
Tyra Biosciences Reports Increased R&D Investment in Q1 2025
4M ago
TYRA
Premium
The Fly
Tyra Biosciences files $500M mixed securities shelf
4M ago
TYRA
Premium
The Fly
Tyra Biosciences reports Q1 EPS (47c), consensus (48c)
4M ago
TYRA
Premium
The Fly
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
4M ago
IDYA
NRIX
Premium
Ratings
Tyra Bioscience’s Promising Clinical Developments and Strong Financial Health Justify Buy Rating
5M ago
TYRA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
